Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.00
Bid: 1,732.50
Ask: 1,733.00
Change: 4.50 (0.26%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,736.50
Low: 1,729.00
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: Pearson, 40p tax, BAE

Sun, 28th Oct 2012 19:28

News Corporation has joined the race for Penguin with a last-minute overture to the directors of Pearson, the media conglomerate that owns the book publisher. Glen Moreno, Pearson's chairman, will put the approach to directors in the next few days. Rupert Murdoch, the chairman and chief executive of News Corp, parent company of The Sunday Times, is understood to have indicated he will make a substantial cash offer ? thought to be about 1bn pounds ? for Penguin, subject to due diligence. A bid by News Corp, which owns one of Penguin's big rivals, Harper Collins, could torpedo the planned merger of Penguin and Random House, owned by Germany's Bertelsmann. Bertelsmann would own 60 per cent of the combined group, which would have nearly 30 per cent of English-language book sales. A union of Penguin and HarperCollins would have a market share of 20 per cent, according to The Sunday Times. In a statement on Sunday, Daily Mail and General Trust (DMGT) said: "In response to media speculation, DMGT confirms that it is currently in talks regarding the future of Northcliffe Media. "No deal or transaction has been agreed, but if these talks move to the point where agreement is reached, an announcement will be made to the market." The statement comes after reports this weekend that DMGT was in talks with David Montgomery, the former chief executive of Mirror Group, over a sale of its regional titles, valuing them at £110m. Mr Montgomery is thought to have secured private equity backing for the deal, which would see DMGT retain a substantial stake in the new venture, The Sunday Telegraph reports. There is ''reason for some optimism'' for the British economy over the coming period, according to Charlie Bean, Deputy Governor at the Bank of England. The economy has been ''bumping along the bottom'' for two years but there are now signs of progress in dealing with problems in the Eurozone and the banking system and expectations of lower inflation, he said. For his part, Chief Secretary to the Treasury Danny Alexander rejected suggestions that austerity is to blame for sluggish growth and said that he would still have backed cuts on the same scale, even if he knew at the time of the 2010 comprehensive spending review that growth over the subsequent two-and-a-half years would be just 0.6%, rather than the 6% that was forecast at the time, The Sunday Telegraph says. Telecoms giant BT, which shocked rivals in June with a £738m gamble on Premier League football, has struck deals for "hundreds" of live matches from Serie A in Italy, Ligue 1 in France and Brasileirao in Brazil. BT will use the matches to help beef up a new sports channel that will be launched next summer. In addition to the Premier League deal, which hands BT the rights to broadcast 38 live matches a year for three years from 2013, it has also signed a £152m deal to show Premiership Rugby for four years from next year. The outlay is thought to be close to £1bn. It is not known how much BT paid for its latest tranche of football rights. The move will put fresh pressure on rival BSkyB, which has built its empire on top-tier football rights and was caught off-guard by BT's entry into the market, The Sunday Telegraph assures.The 40p tax threshold should be raised to £50,000 to stop 1.3m people falling into the higher rate net, a report claims. A dramatic rise in the level at which people pay 40% tax should be brought in to reverse years of dragging more people into paying it, Conservative MPs Kwasi Kwarteng and Priti Patel argue. The 40p tax threshold is due to fall again to £41,450 next year, for most earners, from its current £42,475 level. But in a paper called Motivating The Middle, to be published tomorrow, Mr Kwarteng and Ms Patel will argue for a dramatic turnaround on the fiscal drag that has pulled more people into the 40p tax net. This drag has happened through the threshold rising slower than earnings under New Labour and the level at which 40p tax falls has then been lowered by Chancellor George Osborne as he raises the tax-free personal allowance, says The Financial Mail on Sunday. The Financial Mail on Sunday has established that the mobile phones of three executives at Citigate - one of the leading financial public relations advisers - may have been hacked in 2005 and 2006. A senior Citigate source said he was told by his phone company, O2, that his mobile had been hacked over an extended period from 2005 and advised to contact the police. Several other senior personnel at the firm were told that their phones had also been hacked. 'It is something which could have damaged my professional reputation if word of a deal got out,' he said. A spokesman for Citigate said: 'We were told by our mobile provider around 18 months ago that police were investigating allegations that between 2005 to 2006 attempts by unauthorised parties may have been made to hack into three of our company mobile phones.'The chairman of BAE Systems has rebuffed suggestions that he will stand down as early as next May in the wake of the failed £28bn merger with EADS, the owner of Airbus. However, Dick Olver is expected to come under more pressure from shareholders in the coming weeks, City sources said. Olver, chairman of BAE for eight years, has come in for particular criticism from Invesco Perpetual, BAE's biggest shareholder with a 13.4% stake. Neil Woodford, head of investment at Invesco, also wants Sir Peter Mason, the senior independent director, to go. He is due to stand down in January. Invesco has been backed by Artemis and Henderson, which own a further 2% between them. Woodford is angry that BAE's management, led by Olver and Ian King, chief executive, pursued a risky merger instead of sticking to cutting costs and returning money to shareholders, The Sunday Times says. Britain's faltering nuclear renaissance will receive a boost this week when Hitachi, the Japanese engineering giant, unveils a £700m takeover of Horizon Nuclear Power. The blockbuster deal values Horizon, which has rights to build reactors at Wylfa, on Anglesey, and Oldbury, near Bristol, well beyond what analysts expected it to fetch. Ed Davey, the energy secretary, is expected to herald the deal as an endorsement of the government's policy of enticing developers with the tens of billions in subsidies. Hitachi is expected to provide lucrative roles for British suppliers. Eon and RWE, Horizon's German owners, put the joint venture up for sale in March, citing soaring costs. The plan to build up to six reactors ? three on each site ? was expected to cost at least £20bn. The Germans' withdrawal threw Whitehall's controversial low-carbon energy overhaul into chaos. The government has put the construction of atomic reactors at the heart of its plans to replace fossil-fuelled plants, The Sunday Times reports. Sir Christopher Gent is to stand down as chairman of Glaxo Smith Kline. The pharmaceutical giant has appointed headhunters to search for a successor to Gent, who has held the role since January 2005. He is unlikely to go soon, with City sources indicating one option would be for him to leave at the 2014 shareholder meeting. The exact timing will depend on the choice of replacement. Glaxo declined to comment. Gent, 64, is one of Britain's best-known businessmen. As chief executive of Vodafone, he helped to turn the group into a mobile phone powerhouse, engineering the £112bn purchase of its German rival Mannesmann ? the biggest overseas takeover by a British firm, The Sunday Times writes.AB
More News
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.